Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 3, 2009, Pages

  Lukovac, S ^a   Los, E L ^a   Stellaard, F ^a   Rings, E H H M ^a   Verkade, H J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

fgf15; FGF19; Small intestine; Stable isotope dilution

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; BILE SALT; CHENODEOXYCHOLIC ACID; CYTOKINE; ESSENTIAL FATTY ACID; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR 15; MESSENGER RNA; STABLE ISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE FLOW; BILE SECRETION; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CONTROLLED STUDY; ENTEROHEPATIC CIRCULATION; ESSENTIAL FATTY ACID DEFICIENCY; GENE; HOMEOSTASIS; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SMALL INTESTINE ABSORPTION; SYNTHESIS; WILD TYPE;

ANIMALS; BILE; BILE ACIDS AND SALTS; CACO-2 CELLS; CHENODEOXYCHOLIC ACID; CHOLESTEROL 7-ALPHA-HYDROXYLASE; ENTEROHEPATIC CIRCULATION; FATTY ACIDS, ESSENTIAL; FEEDBACK, BIOCHEMICAL; FIBROBLAST GROWTH FACTORS; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; ISOXAZOLES; KINETICS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER;

EID: 69749098930     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00091.2009     Document Type: Article

References (51)

1. Ballatori N, Fang F, Christian WV, Li N, Hammond CL. Ostα-Ostβ is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. Am J Physiol Gastrointest Liver Physiol 295: G179-G186, 2008.
2. Bergstrom S, Danielsson H. On the regulation of bile acid formation in the rat liver. Acta Physiol Scand 43: 1-7, 1958.
3. Biggemann B, Laryea MD, Schuster A, Griese M, Reinhardt D, Bremer HJ. Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis. Scand J Gastroenterol Suppl 143: 135-141, 1988. (Pubitemid 18210441)
4. Bjorkhem I, Araya Z, Rudling M, Angelin B, Einarsson C, Wikvall K. Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J Biol Chem 277: 26804-26807, 2002.
5. Böhles H, Nocholson JF, Heird JF, Fekl W. Effects of essential fatty acid deficiency on various functions of the rat erythrocyte membrane. Z Ernahrungswiss 18: 112-118, 1979.
6. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 48: 1936-1942, 1988.
7. Ehrström M, Harms-Ringdahl M, Alling C. Osmotic fragility and fluidity of erythrocyte membranes from rats raised on an essential fatty acid deficient diet. Biochim Biophys Acta 644: 175-182, 1972.
8. Eloranta JJ, Kullak-Ublick G. The role of FXR in disorders of bile acid homeostasis. Physiology 23: 286-295, 2008.
9. Gilardi F, Mitro N, Godio C, Scotti E, Caruso D, Crestani M, De Fabiani E. The pharmacological exploitation of cholesterol 7α-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol. Pharmacol Ther 116: 449-472, 2007. (Pubitemid 350116942)
10. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6: 517-526, 2000.
11. Grefhorst A, Elzinga B, Voshol P, Plosch T, Kok T, Bloks V, van der Sluijs F, Havekes L, Romijn J, Verkade H, Kuipers F. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem 277: 34182-34190, 2002.
12. Groothuis GM, Hardonk MJ, Keulemans KP, Nieuwenhuis P, Meijer DK. Autoradiographic and kinetic demonstration of acinar heterogeneity of taurocholate transport. Am J Physiol Gastrointest Liver Physiol 243: G455-G462, 1982.
13. Gutierrez A, Ratliff EP, Andres AM, Huang X, McKeehan WL, Davis RA. Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4. Arterioscler Thromb Vasc Biol 26: 301-306, 2006. (Pubitemid 43732191)
14. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30: 719-730, 1989.
15. Hirohashi T, Suzuki H, Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 274: 15181-15185, 1999. (Pubitemid 129518857)
16. Holman R. The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 70: 405-410, 1960.
17. Hulzebos C, Renfurm L, Bandsma R, Verkade H, Boer T, Boverhof R, Tanaka H, Mierau I, Sauer P, Kuipers F, Stellaard F. Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: application to rodents and humans. J Lipid Res 42: 1923-1929, 2001.
18. Hulzebos C, Wolters H, Plosch T, Kramer W, Stengelin S, Stellaard F, Sauer P, Verkade H, Kuipers F. Cyclosporin A and enterohepatic circulation of bile salts in rats: decreased cholate synthesis but increased intestinal reabsorption. J Pharmacol Exp Ther 304: 356-363, 2003. (Pubitemid 36008949)
19. Hunt MC, Yang YZ, Eggertsen G, Carneheim CM, Gafvels M, Einarsson C, Alexson SEH. The peroxisome proliferator-activated receptor α (PPARα) regulates bile acid biosynthesis. J Biol Chem 275: 28947-28953, 2000. (Pubitemid 30704234)
20. Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2: 217-225, 2005.
21. Ishida H, Yamashita C, Kuruta Y, Yoshida Y, Noshiro M. Insulin is a dominant suppressor of sterol 12α-hydroxylase P450 (CYP8B) expression in rat liver: possible role of insulin in circadian rhythm of CYP8B. J Biochem (Tokyo) 127: 57-64, 2000. (Pubitemid 30094094)
22. Jung D, Inagaki T, Gerard RD, Dawson PA, Kliewer SA, Mangelsdorf DJ, Moschetta A. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res 48: 2693-2700, 2007. (Pubitemid 350272854)
23. Kalaany NY, Mangelsdorf DJ. LXRS AND FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol 68: 159-191, 2006.
24. Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, Gonzalez FJ. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48: 2664-2672, 2007. (Pubitemid 350272851)
25. Kok T, Hulzebos C, Wolters H, Havinga R, Agellon L, Stellaard F, Shan B, Schwarz M, Kuipers F. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J Biol Chem 278: 41930-41937, 2003. (Pubitemid 37310455)
26. Kuipers F, Havinga R, Bosschieter H, Toorop GP, Hindriks FR, Vonk RJ. Enterohepatic circulation in the rat. Gastroenterology 88: 403-411, 1985.
27. Levy E, Garofalo C, Rouleau T, Gavino V, Bendayan M. Impact of essential fatty acid deficiency on hepatic sterol metabolism in rats. Hepatology 23: 848-857, 1996. (Pubitemid 26112001)
28. Levy E, Garofalo C, Thibault L, Dionne S, Daoust L, Lepage G, Roy CC. Intraluminal and intracellular phases of fat absorption are impaired in essential fatty acid deficiency. Am J Physiol Gastrointest Liver Physiol 262: G319-G326, 1992.
29. Levy E, Thibault L, Garofalo C, Messier M, Lepage G, Ronco N, Roy CC. Combined (n-3 and n-6) essential fatty deficiency is a potent modulator of plasma lipids, lipoprotein composition, and lipolytic enzymes. J Lipid Res 31: 2009-2017, 1990.
30. Liu Y, Havinga R, Van der Leij FR, Boverhof R, Sauer PJ, Stellaard F. Dexamethasone exposure of neonatal rats modulates biliary lipid secretion and hepatic expression of genes controlling bile acid metabolism in adulthood without interfering with primary bile acid kinetics. Pediatr Res 63: 375-381, 2008.
31. Lukovac S, Los EL, Stellaard F, Rings EHHM, Verkade HJ. Essential fatty acid deficiency in mice impairs lactose digestion. Am J Physiol Gastrointest Liver Physiol 295: G605-G613, 2008.
32. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science 284: 1362-1365, 1999. (Pubitemid 29289663)
33. Mashige F, Imai K, Osuga T. A simple and sensitive assay of total serum bile acids. Clin Chim Acta 70: 79-86, 1976.
34. Muskiet FA, van Doormaal JJ, Martini IA, Wolthers BG, van der Silk W. Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J Chromatogr 278: 231-244, 1983.
35. Nilsson A, Melin T. Absorption and metabolism of orally fed arachidonic and linoleic acid in the rat. Am J Physiol Gastrointest Liver Physiol 255: G612-G618, 1988. (Pubitemid 19013675)
36. Noshiro M, Usui E, Kawamoto T, Kubo H, Fujimoto K, Furukawa M, Honma S, Makishima M, Honma Ki, Kato Y. Multiple mechanisms regulate circadian expression of the gene for cholesterol 7 α-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis. J Biol Rhythms 22: 299-311, 2007. (Pubitemid 47077307)
37. Pandak WM, Heuman DM, Hylemon PB, Chiang JY, Vlahcevic ZR. Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 α-hydroxylase in rats with biliary fistulas. Gastroenterology 108: 533-544, 1995.
38. Pandak WM, Vlahcevic ZR, Heuman DM, Redford KS, Chiang JY, Hylemon PB. Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 α-hydroxylase. Hepatology 19: 941-947, 1994.
39. Post SM, Twisk J, van der Fits L, de Wit EC, Hoekman MF, Mager WH, Princen HM. Lipoprotein cholesterol uptake mediates up-regulation of bile-acid synthesis by increasing cholesterol 7alpha-hydroxylase but not sterol 27-hydroxylase gene expression in cultured rat hepatocytes. Biochem J 341: 339-346, 1999. (Pubitemid 29373658)
40. Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJEJ, Moen CJA, Muller M, Frants RR, Kasanmoentalib S, Post SM, Princen HMG, Porter JG, Katan MB, Hofker MH, Moore DD. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol 21: 1603-1616, 2007. (Pubitemid 47001085)
41. Schwarz M, Russell DW, Dietschy JM, Turley SD. Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J Lipid Res 39: 1833-1843, 1998.
42. Smit E, Muskiet F, Boersma ER. The possible role of essential fatty acids in the pathophysiology of malnutrition: a review. Prostaglandins Leukot Essent Fatty Acids 71: 241-250, 2004. (Pubitemid 39043660)
43. Socha P, Koletzko B, Swiatkowska E, Pawlovska J, Stolarczyk A, Socha J. Essential fatty acid metabolism in infants with cholestasis. Acta Paediatr 87: 278-283, 1998. (Pubitemid 28134266)
44. Song KH, Li T, Owsley E, Strom S, Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology 49: 297-305, 2009.
45. Spalinger J, Seidman E, Lepage G, Menard D, Gavino V, Levy E. Uptake and metabolism of structured triglyceride by Caco-2 cells: reversal of essential fatty acid deficiency. Am J Physiol Gastrointest Liver Physiol 275: G652-G659, 1998. (Pubitemid 28491818)
46. Stellaard F, Langelaar SA, Kok RM, Jakobs C. Determination of plasma bile acids by capillary gas-liquid chromatography-electron capture negative chemical ionization mass fragmentography. J Lipid Res 30: 1647-1652, 1989. (Pubitemid 19271060)
47. Strandvik B. Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis. Acta Paediatr Scand Suppl 363: 58-63, 1989. (Pubitemid 20086458)
48. Werner A, Havinga R, Bos T, Bloks V, Kuipers F, Verkade H. Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles. Am J Physiol Gastrointest Liver Physiol 288: G1150-G1158, 2005. (Pubitemid 40741067)
49. Werner A, Minich DM, Havinga H, Bloks VW, van Goor H, Kuipers F, Verkade HJ. Fat malabsorption in essential fatty acid-deficient mice is not due to impaired bile formation. Am J Physiol Gastrointest Liver Physiol 283: G900-G908, 2002. (Pubitemid 35033933)
50. Wolters H, Elzinga BM, Baller JFW, Boverhof R, Schwarz M, Stieger B, Verkade HJ, Kuipers F. Effects of bile salt flux variations on the expression of hepatic bile salt transporters in vivo in mice. J Hepatol 37: 556-563, 2002. (Pubitemid 35305533)
51. Zhang M, Chiang JYL. Transcriptional regulation of the human sterol 12α-hydroxylase gene (CYP8B1): roles of hepatocyte nuclear factor 4α (HNF4α) in mediating bile acid repression. J Biol Chem M105117200, 2001. (Pubitemid 37371062)